Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt

對不起，此内容只適用於English。

歷史重覆，禽流抗藥

WHO recommends using Tamiflu (oseltamivir) at 75 mg twice daily to treat A(H5N1) infections and supports stockpiling in advance of a pandemic.

Oseltamivir resistance in H1N1 resulting from H274Y and N294S mutation is now widespread, as published in 2009, 25 years ago.